Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Chapel Hill oncology research firm Heat Biologics is set to go public two weeks from today and has upped the maximum offering price to more than $33.1 million, according to a securities filing. In a previous filing, that total was listed as $24 million. Heat, whose public filing was revealed in May, would join a host of other local life science companies newly represented on Wall Street, such as Quintiles (NYSE: Q), Liposcience (Nasdaq: LPDX) and Chimerix (Nasdaq: CMRX).
Help employers find you! Check out all the jobs and post your resume.
Chapel Hill oncology research firm Heat Biologics is set to go public two weeks from today and has upped the maximum offering price to more than $33.1 million, according to a securities filing. In a previous filing, that total was listed as $24 million. Heat, whose public filing was revealed in May, would join a host of other local life science companies newly represented on Wall Street, such as Quintiles (NYSE: Q), Liposcience (Nasdaq: LPDX) and Chimerix (Nasdaq: CMRX).
Help employers find you! Check out all the jobs and post your resume.
